Liver cancer
Conditions
Interventions
Early recurrence :NA
Late recurrence :NA
Sponsors
Shandong First Medical University and Shandong Academy of Medical Sciences (Shandong Cancer Hospital &Institute)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Precise Translation: Subjects meeting all the following criteria are eligible for this trial: 1..Postoperative pathological confirmation of hepatocellular carcinoma; 2. Pathologically confirmed negative resection margins; 3. Absence of lymph node metastasis or extrahepatic metastasis; 4. No severe failure of major organs (e.g., heart, lung, kidneys); 5. Written informed consent obtained from the patient or their legal representative.
Exclusion criteria
Exclusion criteria: Subjects meeting any of the following criteria will be excluded: 1.Postoperative diagnosis of cholangiocarcinoma or other non-HCC malignancies; 2.Prior liver surgery or pre-operative radiotherapy/chemotherapy; 3.Metastases to extrahepatic organs (e.g., lung, brain); 4.Incomplete clinical/Follow-up records; 5.Perioperative death (<=30 days post-surgery); 6.History of concurrent malignancies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serological indicators:AFP, PIVKA-II, GP73; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver function:ALTASTGGTPLTALBPA; | — |
Countries
China
Contacts
Public ContactRu Kun
Shandong First Medical University and Shandong Academy of Medical Sciences (Shandong Cancer Hospital &Institute)
Outcome results
None listed